Home › Repair › BPC-157 (10mg)
Repair Research Peptide
Body protection compound · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a partial sequence in human gastric juice. This 10mg presentation is offered for laboratory studies of cellular repair processes, angiogenesis, and tissue regeneration in in-vitro and animal models.
The 10 mg presentation exists for work that outgrows a single vial. With double the lyophilised mass, a researcher can either reconstitute to twice the working concentration in the same volume of diluent, or hold concentration constant and double the number of replicates drawn from one vial. The second option is the more useful one in practice: it keeps an entire experimental series on a single lot and batch number, which removes batch-to-batch purity variance as a confounding variable in repair, angiogenesis and fibroblast-migration assays that run across multiple plates or several weeks.
| Compound | BPC-157 |
|---|---|
| Category | Repair |
| CAS Number | 137525-51-0 |
| Form | Lyophilised Powder |
| Appearance | White to off-white solid |
| Purity | 99.301% (this batch) |
| Batch | CS-bc10916 |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values are recorded on the Certificate of Analysis supplied with the compound.
BPC-157 is supplied as a lyophilised (freeze-dried) powder and is readily soluble in bacteriostatic or sterile water. At 10 mg the practical reconstitution range is roughly 1–5 mL, which spans an order of magnitude of stock concentration from one vial — wide enough that most in-vitro dilution series can be prepared without a second lot. Add diluent slowly against the vial wall and allow the cake to dissolve without agitation; do not vortex.
Stock concentrations available from a single 10 mg vial, for reference when planning an in-vitro dilution series:
| 1 mL of diluent | 10 mg/mL stock |
|---|---|
| 2 mL of diluent | 5 mg/mL stock |
| 3 mL of diluent | 3.33 mg/mL stock |
| 5 mL of diluent | 2 mg/mL stock |
In-vitro stock concentrations for laboratory dilution work. Not dosing information.
The compound, the analytical methods and the storage requirements are identical to the 5 mg presentation — only the lyophilised mass in the vial changes. The choice is a workflow one. The 5 mg vial suits a single defined protocol or a pilot run, where the whole vial is reconstituted and consumed inside the 28-day post-reconstitution window with little left over. The 10 mg vial suits replicated or extended work: one batch number covers the full series, cost per milligram is lower, and the wider reconstitution range gives more freedom in setting stock concentration. Against that, a 10 mg vial reconstituted all at once commits more material to the 28-day window, so aliquoting before freezing matters more here than it does at 5 mg.
Researchers combining repair-pathway compounds may also want the BPC-157 + TB-500 pairing, which supplies both compounds as separate vials.
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory. Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS). This batch is verified at 99.301% purity, and a Certificate of Analysis is available for the batch so researchers can verify exactly what they are working with.
BPC-157 is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
Yes. Vital Research Labs supplies research-grade BPC-157 (10mg) to Australian research customers, dispatched domestically. It is provided strictly for in-vitro laboratory research and is not for human or veterinary use.
This batch is verified at 99.301% purity by third-party analytical testing (HPLC for purity, mass spectrometry for identity). A Certificate of Analysis is available for the batch.
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity. Batch-specific values are recorded on the Certificate of Analysis.
The lyophilised powder is stored at -20 degrees C, protected from light and moisture. Once reconstituted for research it is kept at 2-8 degrees C and typically used within 28 days.
No. BPC-157 (10mg) supplied by Vital Research Labs is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.
Vital Research Labs supplies BPC-157 from Australian stock, dispatched from New South Wales. Orders placed before the daily cut-off are dispatched the same business day, Monday to Friday, with tracked delivery Australia-wide including Sydney, Melbourne, Brisbane, Perth and Adelaide.
Orders are dispatched the same business day payment is confirmed, Monday to Friday. Weekend and public holiday orders are dispatched the next business day. Standard and express options are available, and express shipping is free on orders over $200. Every order is sent tracked.
Yes. All orders are packed in plain, unbranded outer packaging with no indication of the contents, and sent tracked via Australia Post or an equivalent carrier.
We accept Visa, Mastercard and American Express, plus Apple Pay and Google Pay, all taken instantly at checkout. Bank transfer is also available if you prefer.
Reconstituting 10mg in 1mL of bacteriostatic water gives 10mg/mL; 2mL gives 5mg/mL; 3mL gives roughly 3.33mg/mL; and 5mL gives 2mg/mL. These are in-vitro stock concentrations for laboratory dilution work only.
It depends on the scale of the work rather than the compound. The 5mg vial fits a single protocol or pilot run consumed inside the 28-day post-reconstitution window. The 10mg vial fits replicated or extended studies, because the whole series stays on one lot and batch number and the cost per milligram is lower. Both are the same compound tested by the same methods.
No. Each presentation is filled and tested as its own lot with its own batch number and Certificate of Analysis. If a study needs every replicate on one lot, order the single presentation that covers the whole requirement rather than mixing the two.